Rosiver (ivermectin)

pCPA File Number: 21019

Negotiation Status:

Concluded without agreement

Indication(s):

Rosacea

Sponsor/Manufacturer:

Galderma Canada Inc.

CDA-AMC Project Number:

Not Applicable

pCPA Engagement Letter Issued:

2018-02-23

Negotiation Process Concluded:

2018-05-23